OBJECTIVE: Telemedicine is increasingly being offered to patients for rheumatology care, but few studies have examined factors associated with telemedicine use or outcomes of telemedicine in rheumatology. The objective of this analysis was to determine factors associated with the use of video telemedicine when offered as part of usual care for follow-up of rheumatoid arthritis (RA). METHODS: Individuals in the Alaska Tribal Health System with a diagnosis of RA were recruited when seeing a rheumatologist either in-person or by video telemedicine, both of which were offered as part of usual care. At the study visit, participants completed the Routine Assessment of Patient Index Data 3 (RAPID3) and a telemedicine perception survey and agreed to a medical record review for demographics and disease characteristics. Data from this visit were analyzed to determine factors associated with using telemedicine for RA, compared to being seen in-person only. RESULTS: Of 122 participants enrolled in the study, 56 (46%) had been seen by telemedicine at least once. Factors associated with telemedicine use in univariate analysis included a higher RAPID3 score, a higher number of rheumatologist visits in the preceding year, more positive perceptions of telemedicine, and seeing a physician who used telemedicine more often. On multivariate analysis, these 4 factors all remained significant. Demographic and other disease-related factors or comorbidities were not associated with telemedicine use. CONCLUSION: When offered as an option for rheumatology care, video telemedicine was more likely to be used by RA patients with higher disease activity and more positive perceptions of telemedicine, and by patients whose physicians used telemedicine more often.
OBJECTIVE: Telemedicine is increasingly being offered to patients for rheumatology care, but few studies have examined factors associated with telemedicine use or outcomes of telemedicine in rheumatology. The objective of this analysis was to determine factors associated with the use of video telemedicine when offered as part of usual care for follow-up of rheumatoid arthritis (RA). METHODS: Individuals in the Alaska Tribal Health System with a diagnosis of RA were recruited when seeing a rheumatologist either in-person or by video telemedicine, both of which were offered as part of usual care. At the study visit, participants completed the Routine Assessment of Patient Index Data 3 (RAPID3) and a telemedicine perception survey and agreed to a medical record review for demographics and disease characteristics. Data from this visit were analyzed to determine factors associated with using telemedicine for RA, compared to being seen in-person only. RESULTS: Of 122 participants enrolled in the study, 56 (46%) had been seen by telemedicine at least once. Factors associated with telemedicine use in univariate analysis included a higher RAPID3 score, a higher number of rheumatologist visits in the preceding year, more positive perceptions of telemedicine, and seeing a physician who used telemedicine more often. On multivariate analysis, these 4 factors all remained significant. Demographic and other disease-related factors or comorbidities were not associated with telemedicine use. CONCLUSION: When offered as an option for rheumatology care, video telemedicine was more likely to be used by RApatients with higher disease activity and more positive perceptions of telemedicine, and by patients whose physicians used telemedicine more often.
Authors: Ian M Ward; Thomas W Schmidt; Charles Lappan; Daniel F Battafarano Journal: Arthritis Care Res (Hoboken) Date: 2016-08-19 Impact factor: 4.794
Authors: Elizabeth D Ferucci; Katherine J Donnithorne; Kathryn R Koller; Amy Swango-Wilson; Jacqueline Pflaum; Anne P Lanier Journal: Qual Saf Health Care Date: 2010-07-23
Authors: John A McDougall; Elizabeth D Ferucci; Janis Glover; Liana Fraenkel Journal: Arthritis Care Res (Hoboken) Date: 2017-08-22 Impact factor: 4.794
Authors: Chad L Deal; Roderick Hooker; Timothy Harrington; Neal Birnbaum; Paul Hogan; Ellen Bouchery; Marisa Klein-Gitelman; Walter Barr Journal: Arthritis Rheum Date: 2007-03
Authors: Jinoos Yazdany; Chris Tonner; Gabriela Schmajuk; Grace A Lin; Amal N Trivedi Journal: Arthritis Care Res (Hoboken) Date: 2014-10 Impact factor: 4.794
Authors: Wei Tang; Sean Inzerillo; Julia Weiner; Leila Khalili; Julia Barasch; Yevgeniya Gartshteyn; Maria Dall'Era; Cynthia Aranow; Meggan Mackay; Anca Askanase Journal: Front Med (Lausanne) Date: 2022-05-20
Authors: Bryant R England; Claire E H Barber; Martin Bergman; Veena K Ranganath; Lisa G Suter; Kaleb Michaud Journal: Arthritis Care Res (Hoboken) Date: 2021-12 Impact factor: 5.178
Authors: Michael D George; Maria I Danila; Daniel Watrous; Shanmugapriya Reddy; Jeffrey Alper; Fenglong Xie; W Benjamin Nowell; Joel Kallich; Cassie Clinton; Kenneth G Saag; Jeffrey R Curtis Journal: Arthritis Care Res (Hoboken) Date: 2021-07-06 Impact factor: 5.178
Authors: Jesús Tornero-Molina; Fernando Sánchez-Alonso; Manuel Fernández-Prada; María-Luisa Bris-Ochaita; Alberto Sifuentes-Giraldo; Javier Vidal-Fuentes Journal: Reumatol Clin (Engl Ed) Date: 2020-10-29
Authors: Annette de Thurah; Andrea Marques; Savia de Souza; Cynthia S Crowson; Elena Myasoedova Journal: Ther Adv Musculoskelet Dis Date: 2022-03-17 Impact factor: 5.346